Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-071548

Director sold 1,737 shares at $41.10 ($71,391)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sanders Corazon (Corsee) D. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-06-10 Sale : show line 1 in the form 10b5-1 −1,737 $41.10 $71,391 7,248 D
Open-market sales · 1,737 sh · avg $41.10 · $71,391
Loading xslF345X05/ownership.xml…